@hotcoppa i'm clearly venting and disgruntled which i apologies for, but i think you can clearly understand why - back to 44 c today, a sell order of 1M @.48, 2M on screen sellers, 280k on screen buyers, big holders are clearly exiting on masse, and no major buy interest post results. Completely the opposite.
This will sit here for at least 12 months in the 40c-50c range at best. I've been sitting in this range for 18months, and mostly frustrated at myself for not bailing. To me its very clear the business is not that concerned about the SP, given they are major holders and no intention to sell but being a family business they're probably happy to build wealth over 20-30yrs, and not concerned about SP because no intention to ever sell. Their wealth will come from dividends in 5-6 yrs time. But for the average punter, who does rely on SP increase as a form of return and are keen to exit in a 12-36 month timeframe, its just not going to happen.
The motives of the major holders and retail investors are not aligned. Its basically a listed family business, and run like one.
- Forums
- ASX - By Stock
- DNA
- Nice cash flow!
Nice cash flow!, page-19
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DNA (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.6¢ |
Change
-0.003(10.3%) |
Mkt cap ! $32.12M |
Open | High | Low | Value | Volume |
2.8¢ | 3.0¢ | 2.6¢ | $6.711K | 245.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 334999 | 2.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.0¢ | 131526 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 334999 | 0.026 |
3 | 386611 | 0.025 |
1 | 320000 | 0.024 |
2 | 100001 | 0.021 |
1 | 100099 | 0.010 |
Price($) | Vol. | No. |
---|---|---|
0.030 | 131526 | 3 |
0.031 | 499883 | 2 |
0.032 | 500000 | 1 |
0.033 | 305891 | 1 |
0.034 | 237420 | 3 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
DNA (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online